TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27089730

Group type: EXPERIMENTAL
Intervention: Cocarnit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22926212

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Zinc and copper supplementation
Number of subjects: 724
Study: 21350422

Group type: EXPERIMENTAL
Intervention: Neuromidin (ipidacrinum) 80 mg/day for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison group (no treatment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neuromidin (ipidacrinum)
Number of subjects: 40
Study: 19035467

Group type: EXPERIMENTAL
Intervention: Exact unconditional CI estimators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Approximate unconditional CI estimators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unconditional two-sided-test-based CI estimators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asymptotic CIs
Number of subjects: 0
Study: 16886930

Group type: EXPERIMENTAL
Intervention: Suprathreshold single and repetitive (2 Hz) electrical stimulation of muscle and skin in cephalic (temporal and trapezius) and extracephalic (anterior tibial) regions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Suprathreshold single and repetitive (2 Hz) electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal summation of muscular and cutaneous pain
Number of subjects: 0
Study: 15623461

Group type: EXPERIMENTAL
Intervention: Low-fat diet (15% of energy from fat)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: High-FV diet (9 servings/d)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combination low-fat/high-FV diet
Number of subjects: 122

Group type: COMPARATOR
Intervention: Nonintervention (control)
Number of subjects: 122
Study: 11733884

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training and a conventional exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional exercise program only (Control)
Number of subjects: 60
Study: 9161368

Group type: COMPARATOR
Intervention: Without stabilization of the contralateral leg
Number of subjects: 75

Group type: COMPARATOR
Intervention: With a bar in front of the ankle joint of the contralateral leg
Number of subjects: 75

Group type: COMPARATOR
Intervention: With the contralateral leg strapped just above the level of the malleoli and the muscles of that leg induced reciprocally to perform isometric contractions with respect to the testing leg
Number of subjects: 75
Study: 7509894

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg once daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2889828

Group type: EXPERIMENTAL
Intervention: Fixed partial denture supported by blade-vent implant
Number of subjects: 272

Group type: COMPARATOR
Intervention: Removable partial denture
Number of subjects: 272
Study: 31279221

Group type: EXPERIMENTAL
Intervention: unguided ICBT‐P
Number of subjects: 94

Group type: COMPARATOR
Intervention: unguided ICBT‐S
Number of subjects: 94

Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 94
Study: 28829001

Group type: COMPARATOR
Intervention: Single dose of 34 mg of ferrous sulfate (group A)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Double dose of 34 mg of ferrous sulfate (group B)
Number of subjects: 172
Study: 25733343

Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management (DSM) intervention delivered by trained nurses
Number of subjects: 85

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 85
Study: 23838939

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (6 x 9 ufc b.i.d) (n = 29)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 66
Study: 21563507

Group type: EXPERIMENTAL
Intervention: Xuebijing Injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (routine therapy)
Number of subjects: 80
Study: 19404670

Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction (MVC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Submaximal contraction at 10% to 90% of MVC
Number of subjects: 13
Study: 16472935

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy (PMRT)
Number of subjects: 1010
Study: 12614996

Group type: EXPERIMENTAL
Intervention: 3 g/day of ethyl-eicosapentaenoic acid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nonsmoking women
Number of subjects: 72
Study: 10839906

Group type: EXPERIMENTAL
Intervention: Bambuterol (20 mg orally 2 hours before anesthesia)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 28
Study: 9165607

Group type: EXPERIMENTAL
Intervention: Desmopressin (Minirin, DDAVP) administered with food or 90 minutes after a meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Desmopressin (Minirin, DDAVP)
Number of subjects: 16
Study: 8409152

Group type: EXPERIMENTAL
Intervention: Intramuscular cefoperazone, 1 gm every 12 hours, for 10 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intramuscular ceftriaxone, 1 gm every 24 hours, for 10 days
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 104
Study: 3512778

Group type: EXPERIMENTAL
Intervention: Methylpentynol, 200 mg/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29529161

Group type: COMPARATOR
Intervention: Fructose control beverage (glucose and fructose)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Large servings of apple (410 g)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Large servings of apple juice (340 mL)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Whole apple
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Satiety scores
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Glycemic response
Number of subjects: 73
Study: 26956652

Group type: EXPERIMENTAL
Intervention: Behavioral Activation Exercise Intervention (EX)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 29
Study: 25185430

Group type: EXPERIMENTAL
Intervention: Allopurinol administration
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22284333

Group type: EXPERIMENTAL
Intervention: CATMN system
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional fluoroscopic technique
Number of subjects: 26
Study: 20623003

Group type: EXPERIMENTAL
Intervention: Native banana starch (NBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soy milk (control)
Number of subjects: 0
Study: 18615388

Group type: EXPERIMENTAL
Intervention: 10 % CHO beverage (15 mL . kg (‐1) . hr (‐1))
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water (H2O)
Number of subjects: 16
Study: 16093979

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 10219

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10219
Study: 12439601

Group type: EXPERIMENTAL
Intervention: 24-hour intravenous infusions of methotrexate (MTX)
Number of subjects: 20
Study: 11986564

Group type: EXPERIMENTAL
Intervention: Adenosine with low-level exercise (adenosine-Ex)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Adenosine alone
Number of subjects: 41
Study: 9522108

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 8012639

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 2658040

Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (ATF)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 30782915

Group type: EXPERIMENTAL
Intervention: STEP clinic care including self-monitoring instructions, BP monitor, sleep apnoea screening, dietary counselling, review of BP monitoring records, and medication adjustment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care with neurologist consultation and recommendations for secondary prevention sent to primary care providers.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: STEP clinic care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 29270490

Group type: EXPERIMENTAL
Intervention: QPI‐1002 0.5 mg/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: QPI‐1002 1.5 mg/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: QPI‐1002 5.0 mg/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: QPI‐1002 10.0 mg/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined QPI‐1002 cohorts
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 16
Study: 25640831

Group type: EXPERIMENTAL
Intervention: Living Books program
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Living Letters program
Number of subjects: 508

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 508
Study: 23650501

Group type: EXPERIMENTAL
Intervention: 10 hours of visual speed of processing training (on-site or at-home)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Attention control group using computerized crossword puzzles for 10 hours
Number of subjects: 681
Study: 21402549

Group type: EXPERIMENTAL
Intervention: rAd5 HIV-1 gag vaccine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 18959773

Group type: EXPERIMENTAL
Intervention: Acyclovir and adjuvant dexamethasone
Number of subjects: 372

Group type: COMPARATOR
Intervention: Acyclovir and placebo
Number of subjects: 372
Study: 16424444

Group type: EXPERIMENTAL
Intervention: salmeterol/fluticasone propionate 50/500 microg twice daily
Number of subjects: 140

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study: 12616578

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) with exposure-based treatment
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) with nonexposure-based treatment
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) with both exposure and nonexposure-based treatments
Number of subjects: 113
Study: 11127455

Group type: EXPERIMENTAL
Intervention: Transvaginal progesterone gel (90 mg on alternate days) with estradiol (1 mg/day for three weeks then 2 mg/day for one week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Estradiol/MPA therapy (10 mg/day placebo for MPA)
Number of subjects: 18
Study: 9187989

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with a pulse pressure of 10 to 20 mmHg and a frequency of 60 to 80 beats/min
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonpulsatile perfusion
Number of subjects: 80
Study: 8262689

Group type: EXPERIMENTAL
Intervention: Morphine, 0.2 mg/kg-1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31478254

Group type: EXPERIMENTAL
Intervention: Overweight patients (BMI category 1)
Number of subjects: 11239

Group type: EXPERIMENTAL
Intervention: Obese patients (BMI category 2)
Number of subjects: 11239

Group type: EXPERIMENTAL
Intervention: Obese patients (BMI category 3)
Number of subjects: 11239
Study: 29464745

Group type: EXPERIMENTAL
Intervention: Self‐regulatory efficacy improvement program led by school nurses
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 79
Study: 27569274

Group type: EXPERIMENTAL
Intervention: Ramucirumab with eribulin
Number of subjects: 141

Group type: COMPARATOR
Intervention: Eribulin alone
Number of subjects: 141
Study: 24607675

Group type: EXPERIMENTAL
Intervention: MTO housing voucher intervention
Number of subjects: 2829

Group type: COMPARATOR
Intervention: Control group (no voucher)
Number of subjects: 2829
Study: 22589290

Group type: EXPERIMENTAL
Intervention: Foldable iris-fixated phakic intraocular lens (PIOL) implantation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Femtosecond laser-assisted LASIK
Number of subjects: 46
Study: 20216095

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed 100% whey protein formula (PHF‐W)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intact protein cow's milk formula (CMF)
Number of subjects: 12
Study: 18625896

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) 0.5 microg x kg(‐1) x min(‐1) during rewarming period
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (dextrose 5% in water)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 100
Study: 16107437

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E gp120 HIV vaccine
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Daily tenofovir HIV prophylaxis
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Community outreach intervention
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Educational campaigns
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Preparatory cohort
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Seroconverter cohort
Number of subjects: 1209
Study: 12122623

Group type: EXPERIMENTAL
Intervention: Lidocaine HCl aerosol (4 mg/kg of 10% lidocaine HCl applied eight times daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaCl (2 ml of 0.9% NaCl applied eight times daily)
Number of subjects: 60
Study: 10360414

Group type: EXPERIMENTAL
Intervention: Standardized interpersonal psychotherapy
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with nortriptyline
Number of subjects: 160
Study: 7732992

Group type: EXPERIMENTAL
Intervention: Thrombolysis with intravenous tissue plasminogen activator or urokinase
Number of subjects: 1229
Study: 1742488

Group type: EXPERIMENTAL
Intervention: AP score < 130
Number of subjects: 399

Group type: COMPARATOR
Intervention: AP score ≥ 130
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: AP scores
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: BG scores
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Low AP score
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: BG
Number of subjects: 399
Study: 6816626

Group type: EXPERIMENTAL
Intervention: Tube extension to terbutaline sulphate aerosol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ordinary actuator
Number of subjects: 23
Study: 30727982

Group type: EXPERIMENTAL
Intervention: Phaco‐viscocanalostomy with Ologen® implant (OloPhacovisco group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Phaco‐viscocanalostomy (Phacovisco group)
Number of subjects: 79
Study: 29398571

Group type: EXPERIMENTAL
Intervention: Vegan eating plan
Number of subjects: 45

Group type: COMPARATOR
Intervention: Portion-controlled eating plan
Number of subjects: 45
Study: 26988845

Group type: EXPERIMENTAL
Intervention: L-based supplement
Number of subjects: 52

Group type: COMPARATOR
Intervention: No supplement (non-treated group)
Number of subjects: 52
Study: 25003921

Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation plus pelvic floor muscle training
Number of subjects: 48
Study: 21895920

Group type: EXPERIMENTAL
Intervention: Mitiglinide (5-20 mg/meal)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Nateglinide (60-120 mg/meal)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Mitiglinide
Number of subjects: 225

Group type: COMPARATOR
Intervention: Nateglinide
Number of subjects: 225

Group type: COMPARATOR
Intervention: Mitiglinide and Nateglinide
Number of subjects: 225
Study: 19292750

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified maize-soy flour (Likuni Phala, LP)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ready-to-use fortified spread (FS)
Number of subjects: 176
Study: 17485918

Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Radioiodine treatment (3.3-5.6 GBq)
Number of subjects: 35
Study: 15205198

Group type: COMPARATOR
Intervention: Paclitaxel-Carboplatin (CRP-PCT) - CRP 6 AUC and PCT 175 mg/m² every 3 weeks for six cycles
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Vinorelbine (VRL-PCT) - VRL 25 mg/m² and PCT 135 mg/m² every 2 weeks for nine cycles
Number of subjects: 360
Study: 11579369

Group type: EXPERIMENTAL
Intervention: Captopril (up to 75 mg/d)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Metoprolol (up to 200 mg/d)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Captopril and Metoprolol (both)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 250

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 250
Study: 9540294

Group type: EXPERIMENTAL
Intervention: 32 h on-call shift
Number of subjects: 16
Study: 7986470

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion (2 ng/kg/min) with 3% saline infusion (0.1 mL/kg/min)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 3% saline infusion (0.1 mL/kg/min) alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Phenylephrine infusion with 3% saline infusion (0.1 mL/kg/min)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion (2 ng/kg/min) alone
Number of subjects: 13
Study: 2645421

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg orally every 12 hours for 14 days
Number of subjects: 249

Group type: COMPARATOR
Intervention: Trimethoprim 160 mg plus Sulfamethoxazole 800 mg orally every 12 hours for 14 days
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg
Number of subjects: 249

Group type: COMPARATOR
Intervention: Trimethoprim 160 mg plus Sulfamethoxazole 800 mg
Number of subjects: 249
Study: 31992372

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (20 g/d)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sunflower oil (20 g/d)
Number of subjects: 68
Study: 30630494

Group type: EXPERIMENTAL
Intervention: Maxm Skate rehabilitation program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard rehabilitative care
Number of subjects: 116
Study: 29017565

Group type: EXPERIMENTAL
Intervention: Qishen granules (QSG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 25575488

Group type: EXPERIMENTAL
Intervention: Vortioxetine 15 mg
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg (active reference)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study: 24469530

Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sertraline therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Residual insomnia symptoms after treatment
Number of subjects: 202
Study: 21842145

Group type: COMPARATOR
Intervention: Formocresol
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Ferric sulphate
Number of subjects: 107
Study: 19577132

Group type: EXPERIMENTAL
Intervention: Continuous force of 225 cN for 8 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intermittent force of 225 cN for 8 weeks (14 days of force application, 3 days of rest, then 4 days of force application repeated for 6 weeks)
Number of subjects: 8
Study: 17295689

Group type: EXPERIMENTAL
Intervention: HICC-containing deodorants (200, 600, and 1800 p.p.m.)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HICC-containing deodorants (200 p.p.m.)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Patch test thresholds of HICC solutions
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Patch test thresholds of HICC-scented deodorants
Number of subjects: 15
Study: 16029507

Group type: EXPERIMENTAL
Intervention: Behavioral intervention program (increased intake of calcium-rich foods and weight-bearing physical activity)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 30
Study: 12014291

Group type: EXPERIMENTAL
Intervention: 12-session 24-hour cognitive-behavioral therapy program
Number of subjects: 0
Study: 9440372

Group type: COMPARATOR
Intervention: 0 g fat meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: 15 g fat meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 30 g fat meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 40 g fat meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 g fat meal
Number of subjects: 8
Study: 8586298

Group type: COMPARATOR
Intervention: Intrauterine Insemination (IIU)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fallopian Tube Sperm Perfusion (PTE)
Number of subjects: 60
Study: 2151278

Group type: EXPERIMENTAL
Intervention: Zoladex depot alone, 3.6 mg subcutaneously every 28 days
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Zoladex depot plus cyproterone acetate (CPA), 200 mg/day orally
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Zoladex plus CPA
Number of subjects: 328

Group type: COMPARATOR
Intervention: Zoladex depot alone
Number of subjects: 328
Study: 345826

Group type: EXPERIMENTAL
Intervention: Phenelzine (mean dose of 78 mg/day for 3 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: SCL‐90
Number of subjects: 19
Study: 31704948

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 550

Group type: COMPARATOR
Intervention: Without Simvastatin (WS)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 550